1 of 39

HYPERTENSION

PRESENTATION FROM O.P.D UNIT OF SDH

PRESENTED BY

VICTOR OGUNTUNDE

2 of 39

LEARNING OBJECTIVES

By the end of the presentation, one should be able to;

  1. Define hypertension(HPT)
  2. Know the types of HPT
  3. Know the Classifications of HPT
  4. Know the aetiology
  5. Know the management of HPT
  6. Debrief

3 of 39

OVERVIEW

  • Hypertension is defined as systolic blood pressure(SBP) of 140mmHg or more, and/ or a diastolic blood pressure(DBP) of 90mmHg or more, or taking antihypertensives
  • The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC 7) classifies BP for adults(>/= 18yrs) as follows:

4 of 39

CLASSIFICATION

SYSTOLIC (MMHG)

DIASTOLIC (MMHG)

Normal

<120

<80

Pre-hypertensive

120-139

80-89

Stage I

140-159

90-99

Stage II

≥160

≥100

5 of 39

OVERVIEW CONT'D

  • HPT may be primary ( due to environmental or genetic causes) or secondary ( due to etiologies such as renal, vascular and endocrine causes)
  • Primary HPT or Essential HPT accounts for 90-95% of adult cases and secondary HPT accounts for 5-10%

6 of 39

TYPES OF HYPERTENSION

  • Primary or Essential
  • 95%
  • No underlying course
  • Secondary Hypertension
  • Underlying course

7 of 39

SECONDARY CAUSES

  • Renal
  • Parenchymal
  • Vascular
  • Others

  • Endocrine
  • Miscellaneous
  • Unknown

8 of 39

HAEMODYNAMIC PATTERN IN HYPERTENSION

  • Young : ↑BP = ↑CO X TPR
  • Elderly : ↓ BP = ↑CO X ↑↑ TPR

9 of 39

AETIOLOGY OF SYSTEMIC HYPERTENSION

A. Renal (80%)

  • AGN
  • CGN,
  • CPN,
  • Polycyst. K.D
  • Renal Artery stenosis

B. Endocrine

  • Adrenal
  • Primary aldosteronism
  • Cushing’s syndrome
  • Pheochromocytoma

  • Acromegaly

  • Exogenous hormone
  • Oral contraceptive
  • Glucocorticoids

  • Hypothyroidism &
  • Hyperparathyroidism

10 of 39

AETIOLOGY OF �SYSTEMIC HYPERTENSION

  • Others
  • Coarctation of the aorta
  • Pregnancy Induced HPT (Pre-eclampsia)
  • Sleep Apnea Syndrome.

11 of 39

DISEASES ATTRIBUTABLE TO HYPERTENSION

HYPERTENSION

Gangrene of the Lower Extremities

Heart Failure

Left Ventricular Hypertrophy

Myocardial Infarction

Coronary Heart Disease

Aortic Aneurym

Blindness

Chronic Kidney Failure

Stroke

Preeclampsia/Eclampsia

Cerebral Hemorrhage

Hypertensive encephalopathy

Adapted from Dustan HP et al. Arch Intern Med. 1996; 156: 1926-1935

12 of 39

TARGET ORGAN DAMAGE

  • Heart
  • Left ventricular hypertrophy
  • Angina or myocardial infarction
  • Heart failure
  • Brain
  • Stroke or transient ischemic attack
  • Chronic kidney disease
  • Peripheral arterial disease
  • Retinopathy

13 of 39

CVD RISK

  • The BP relationship to risk of CVD is continuous, consistent, and independent of other risk factors.
  • Prehypertension signals the need for increased education to reduce BP in order to prevent hypertension.

14 of 39

DIAGNOSIS

CLINICAL MANIFESTATIONS

  • No specific complains or manifestations other than elevated systolic and/or diastolic BP (Silent Killer )
  • Morning occipital headache
  • Dizziness
  • Fatigue
  • In severe hypertension, epistaxis or blurred vision

15 of 39

SELF-MEASUREMENT OF BP

  • Provides information on:
  • Response to antihypertensive therapy
  • Improving adherence with therapy
  • Evaluating white-coat HTN
  • Home measurement of >135/85 mmHg is generally considered to be hypertensive.
  • Home measurement devices should be checked regularly.

16 of 39

MEASURING BLOOD PRESSURE

  • Patient seated quietly for at least 5minutes in a chair, with feet on the floor and arm supported at heart level
  • An appropriate-sized cuff (cuff bladder encircling at least 80% of the arm)
  • At least 2 measurements

17 of 39

MEASURING BLOOD PRESSURE CONT’D

  • Systolic Blood Pressure is the point at which the first of 2 or more sounds is heard
  • Diastolic Blood Pressure is the point of disappearance of the sounds (Korotkoff 5th)
  • Ambulatory BP Monitoring - information about BP during daily activities and sleep.
  • Correlates better than office measurements with target-organ injury.

18 of 39

LABORATORY TESTS

  • Routine Tests
  • Electrocardiogram
  • Urinalysis
  • Blood glucose,
  • Serum potassium, creatinine, or the corresponding estimated GFR, and calcium
  • Lipid profile, after 9- to 12-hour fast, that includes high-density and low-density lipoprotein cholesterol, and triglycerides
  • Optional tests
  • Measurement of urinary albumin excretion or albumin/creatinine ratio
  • More extensive testing for identifiable causes is not generally indicated unless BP control is not achieved

19 of 39

TREATMENT OVERVIEW

  • Goals of therapy
  • Lifestyle modification
  • Pharmacologic treatment
  • Algorithm for treatment of hypertension
  • Follow up and monitoring

20 of 39

�GOALS OF THERAPY

  • Reduce Cardiac and renal morbidity and mortality.
  • Treat to BP <140/90 mmHg or BP <130/80 mmHg in patients with diabetes or chronic kidney disease.

21 of 39

NON PHARMACOLOGICAL �TREATMENT OF HYPERTENSION

Avoid harmful habits ,smoking ,alcohal

Reduce salt and high fat diets

Loose weight , if obese

Regular exercise

DASH

diet

22 of 39

LIFE STYLE MODIFICATIONS

  • Lose weight, if overweight
  • Increase physical activity
  • Reduce salt intake
  • Stop smoking
  • Limit intake of foods rich in fats and cholesterol
  • Increase consumption of fruits and vegetables
  • Limit alcohol intake

23 of 39

LIFESTYLE MODIFICATION

MODIFICATION

APPROXIMATE SBP REDUCTION�(RANGE)

Weight reduction

5–20 mmHg / 10 kg weight loss

Adopt DASH eating plan

8–14 mmHg

Dietary sodium reduction

2–8 mmHg

Physical activity

4–9 mmHg

Moderation of alcohol consumption

2–4 mmHg

24 of 39

ANTIHYPERTENSIVE DRUGS

Continue….

AT1 receptor

ARB

25 of 39

ANTIHYPERTENSIVE DRUGS

CLASS OF DRUGS

EXAMPLE

INITIATING DOSE

USUAL MAINTENANCE DOSE

Diuretics

Hydrochlorothiazide

12.5 mg o.d

12.5-25 mg o.d

β-blockers

Atenolol

25-50 mg o.d

50-100 mg o.d

Calcium channel blockers

Amlodipine

2.5-5 mg o.d

5-10 mg o.d

α-blockers

prazosin

2.5 mg o.d

2.5-10mg o.d

ACE- inhibitors

ramipril

1.25-5 mg o.d

5-20 mg o.d

Angiotensin-II receptor blockers

Losartan

25-50 mg o.d

50-100 mg o.d

26 of 39

DIURETICS

Example: Hydrochlorothiazide

  • Act by decreasing blood volume and cardiac output
  • Decrease peripheral resistance during chronic therapy
  • Drugs of choice in elderly hypertensives

Side effects

  • Hypokalaemia
  • Hyponatraemia
  • Hyperlipidaemia
  • Hyperuricaemia (hence contraindicated in gout)
  • Hyperglycaemia (hence not safe in diabetes)
  • Not safe in renal and hepatic insufficiency

27 of 39

BETA BLOCKERS

Example: Atenolol, Metoprolol, nebivolol,

  • Block β1 receptors on the heart
  • Block β2 receptors on kidney and inhibit release of renin
  • Decrease rate and force of contraction and thus reduce cardiac output
  • Drugs of choice in patients with co-existent coronary heart disease

Side effects

  • lethargy, impotency, bradycardia
  • Not safe in patients with co-existing asthma and diabetes
  • Have an adverse effect on the lipid profile

28 of 39

CALCIUM CHANNEL BLOCKERS

Example: Amlodipine

  • Block entry of calcium through calcium channels
  • Cause vasodilation and reduce peripheral resistance
  • Drugs of choice in elderly hypertensives and those with co-existing asthma
  • Neutral effect on glucose and lipid levels

Side effects

Flushing, headache, Pedal edema

29 of 39

ACE INHIBITORS

Example: Ramipril, Lisinopril, Enalapril

  • Inhibit ACE and formation of angiotensin II and block its effects
  • Drugs of choice in co-existent diabetes mellitus, Heart failure

Side effects

dry cough, hypotension, angioedema

30 of 39

ANGIOTENSIN II RECEPTOR BLOCKERS

Example: Losartan

  • Block the angiotensin II receptor and inhibit effects of angiotensin II
  • Drugs of choice in patients with co-existing diabetes mellitus

Side effects

safer than ACEI, hypotension,

31 of 39

ALPHA BLOCKERS

Example: prazosin

  • Block a-1 receptors and cause vasodilation
  • Reduce peripheral resistance and venous return
  • Exert beneficial effects on lipids and insulin sensitivity
  • Drugs of choice in patients with co-existing BPH

Side effects

Postural hypotension,

32 of 39

ANTIHYPERTENSIVE THERAPY:�SIDE-EFFECTS AND CONTRAINDICATIONS

CLASS OF DRUG

MAIN SIDE-EFFECTS

CONTRAINDICATIONS/ SPECIAL PRECAUTIONS

Diuretics Anuria (e.g. Hydrochlorothiazide)

Electrolyte imbalance, total and LDL cholesterol levels, , HDL cholesterol levels, glucose levels, uric acid levels

Hypersensitivity

β-blockers (e.g. Atenolol) Conduction, Diabetes, cardiac

Impotence, Bradycardia, Fatigue

Bradycardia, disturbances, Asthma, Severe failure

33 of 39

ALGORITHM FOR �TREATMENT OF HYPERTENSION

Not at Goal Blood Pressure (<140/90 mmHg) �(<130/80 mmHg for those with diabetes or chronic kidney disease)

Initial Drug Choices

Drug(s) for the compelling indications

Other antihypertensive drugs (diuretics, ACEI, ARB, BB, CCB) �as needed.

With Compelling �Indications

Lifestyle Modifications

Stage 2 Hypertension(SBP >160 or DBP >100 mmHg) �2-drug combination for most (usually thiazide-type diuretic and �ACEI, or ARB, or BB, or CCB)

Stage 1 Hypertension�(SBP 140–159 or DBP 90–99 mmHg)� Thiazide-type diuretics for most. �May consider ACEI, ARB, BB, CCB, �or combination.

Without Compelling �Indications

Not at Goal �Blood Pressure

Optimize dosages or add additional drugs �until goal blood pressure is achieved.�Consider consultation with hypertension specialist.

34 of 39

CHOICE OF DRUG

Condition

Preferred drugs

Other drugs that can be used

Drugs to be avoided

Asthma

Calcium channel blockers

α-blockers/Angiotensin-II receptor blockers/Diuretics/ ACE-inhibitors

β-blockers

Diabetes mellitus

α-blockers/ACE inhibitors/Angiotensin-II receptor blockers

Calcium channel blockers

Diuretics/ b-blockers

High cholesterol levels

α-blockers

ACE inhibitors/ A-II receptor blockers/ Calcium channel blockers

β-blockers/ Diuretics

Elderly patients

Calcium channel blockers/ Diuretics

β-blockers/ACE-inhibitors/Angiotensin-II receptor blockers/- blockers

(above 60 years)

BPH

α-blockers

β-blockers/ ACE inhibitors/ Angiotensin-II receptor blockers/ Diuretics/ Calcium channel blockers

35 of 39

ANTIHYPERTENSIVE THERAPY: SIDE-EFFECTS AND CONTRAINDICATIONS (CONT’D)

CLASS OF DRUG

Main side-effects

Contraindications/ Special Precautions

Calcium channel blockers (e.g. Amlodipine, Diltiazem)

Pedal edema, Headache

Non-dihydropyridine CCBs (e.g diltiazem) – Hypersensitivity, Bradycardia, Conduction disturbances, CHF, LV, dysfunction.

α-blockers (e.g. prazosin)

Postural hypotension

Hypersensitivity

ACE-inhibitors (e.g. Lisinopril)

Cough, Hypotension, Angioneurotic edema

Hypersensitivity, Pregnancy, Bilateral renal artery stenosis

Angiotensin-II receptor blockers (e.g. Losartan)

Headache, Dizziness

Hypersensitivity, Pregnancy, Bilateral renal artery stenosis

36 of 39

1999 WHO-ISH guidelines

CONDITION

PREFERRED DRUGS

Pregnancy

Nifedipine, labetalol, hydralazine, beta-blockers, methyldopa, prazosin

Coronary heart disease

Beta-blockers, ACE inhibitors, Calcium channel blockers

Congestive heart failure

ACE inhibitors, beta-blockers

37 of 39

CAUSES OF �RESISTANT HYPERTENSION

  • Improper BP measurement
  • Excess sodium intake
  • Inadequate diuretic therapy
  • Medication
  • Inadequate doses
  • Drug actions and interactions (e.g., (NSAIDs), illicit drugs, sympathomimetic, OCP)
  • Over-the-counter drugs and some herbal supplements
  • Excess alcohol intake
  • Identifiable causes of HTN

38 of 39

TAKE HOME MESSAGE

  • Hypertension is a major cause of morbidity and mortality, and needs to be treated
  • It is an extremely common condition; however it is still under-diagnosed and undertreated
  • Hypertension is easy to diagnose and easy to treat
  • Aim of the management is to save the target organ from the deleterious effect
  • Besides pharmacology we have other choices and one has to be acquainted with that choice
  • Life style modification should always be encouraged in all Hypertensive patients

39 of 39

ANY QUESTIONS?